William G. Rice
Chair, President & CEO · Aptose Biosciences Inc.
IndividualBuying only
- 2024
- Jul 1, 2026
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at William G. Rice's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BVF PARTNERS L P - $173.67M in KYMR purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $172.50M in KYMR purchases and sales in the last 12 months
- Keith S. Manchester - $154.47M in ROIV purchases and sales in the last 12 months
- QVT Financial LP - $147.38M in ROIV purchases and sales in the last 12 months
- Daniel Allen Gold - $147.38M in ROIV purchases and sales in the last 12 months
- ULSE Inc. - $146.25M in ULS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is William G. Rice?
William G. Rice is a corporate insider, tracked as Chair, President & CEO of Aptose Biosciences Inc. (APTO). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did William G. Rice last file a Form 4?
The most recent primary Form 4 on record is dated 1 July 2026, one of 2 filings going back to 2024.
Has William G. Rice been buying or selling stock?
Recorded transactions: 2 open-market purchases ($20K) and 0 open-market sales across all tracked filings.
